Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Deep learning enabled decision support systems in epilepsy surgery: a scoping review.

npj health systems·2026
Same author

Impact of a Real-Time Virtual Rounding Queue on Neonatal Intensive Care Unit Rounding Practices: Survey Study of Clinicians' Perceptions.

JMIR pediatrics and parenting·2026
Same author

Biopsychosocial Determinants of Frailty in Older People Living With HIV in China: A Bayesian Network Analysis.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same author

Knowledge and perspectives on pharmacogenomic-guided antidepressant treatment among psychiatrists and primary care practitioners.

Pharmacogenetics and genomics·2026
Same author

Implementation of a Real-Time Virtual Rounding Queue on Neonatal Intensive Care Unit Rounding Practices: A Survey of Clinicians' Perceptions.

JMIR pediatrics and parenting·2026
Same author

Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilisation in depression? Real-world evidence from a large health system.

EBioMedicine·2026
Same journal

Sensitivity Analyses of a Scoring System for a Contraception Decision Aid.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Improving electronic health record processing of large language models via retrieval-augmented generation: A case study on dietary supplements.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Developing a User-Centered Mobile Application Prototype: Bridging Lower-Limb Fracture Care from Skilled Nursing Facility and Back to the Community.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

KERAP: A Knowledge-Enhanced Reasoning Approach for Accurate Zero-shot Diagnosis Prediction Using Multi-agent LLMs.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Automating Adjudication of Cardiovascular Events Using Large Language Models.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Predictive Factors and State-Level Barriers to Postpartum Birth Control Usage in the United States: Insights from PRAMS Phase 8.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 24, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

天然物データベースの探索と比較：全人的健康研究に向けて

Xiaoyi Chen1, Meijia Song2, Yu Hou1

  • 1Division of Computational Health Sciences, Department of Surgery, University of Minnesota, Minneapolis, MN, United States.

AMIA ... Annual Symposium proceedings. AMIA Symposium
|February 23, 2026
PubMed
まとめ
この要約は機械生成です。

COCONUT、NP-MRD、GSRSなどの天然物（NP）データベースは断片的であり、全人的健康研究の妨げとなっている。これらの重要な創薬リソースの可能性を最大限に引き出すためには、より大きな統合が必要である。

キーワード:
天然物データベース創薬全人的健康研究データ統合COCONUTNP-MRDGSRS

さらに関連する動画

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1000
Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products
11:13

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products

Published on: March 12, 2020

11.6K

関連する実験動画

Last Updated: Feb 24, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1000
Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products
11:13

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products

Published on: March 12, 2020

11.6K

科学分野:

  • 創薬と開発
  • 医薬品化学
  • 化学生物学

背景:

  • 天然物（NP）は創薬において重要ですが、データはデータベース全体に断片化しています。
  • この断片化は、全人的健康研究のための包括的な分析を制限します。
  • 既存のNPデータベースは相互運用性が欠如しており、データ駆動型インサイトを妨げています。

研究 の 目的:

  • 3つの主要な天然物データベース（COCONUT、NP-MRD、GSRS）を比較すること。
  • それらの範囲、構造表現、メタデータの完全性、およびアクセス可能性を評価すること。
  • NPデータベース統合の強化のためのギャップと機会を特定すること。

主な方法:

  • COCONUT、NP-MRD、GSRSの比較分析。
  • 化学的多様性、スペクトルデータ、規制情報を含むデータベースコンテンツの評価。
  • データアクセス可能性と相互運用性の評価。

主要な成果:

  • COCONUTは化学的多様性に優れ、NP-MRDはスペクトル/物理的特性に優れ、GSRSは規制分類に優れています。
  • データベース間の重複は限定的であり、データの冗長性とギャップが大きいことを示しています。
  • これらのNPデータベース内での医療および製薬情報の統合には、かなりのギャップが存在します。

結論:

  • 現在のNPデータベースは、断片化のため、包括的な全人的健康研究には不十分です。
  • 計算モデルを天然物研究で進歩させるためには、相互運用性とデータハーモナイゼーションの強化が不可欠です。
  • 統合されたNPリソースの開発は、データ駆動型創薬と医薬品化学をサポートするために不可欠です。